Asia Beauty Market Trends 2026: Four Shifts and What They Mean for Cosmetic Testing
Asia remains the most dynamic region in the global beauty industry, and also one of the most demanding. Consumers there compare ingredients, read labels and expect proof. For brands, every new trend comes with a new question: how do you demonstrate that the product actually does what it claims?
Ahead of in-cosmetics Asia 2026 in Bangkok, here are the four trends shaping the Asian beauty market, the tests that can substantiate the claims they generate, and a closer look at Thailand, the host country.
Four trends shaping the Asia beauty market
1. Skin barrier and microbiome: efficacy without irritation
Postbiotic blends and formulas targeting lipid balance are becoming the norm, all the more so as actives with well-substantiated properties reach the market. The new expectation is what experts call “barrier-safe potency”: delivering the expected efficacy without compromising tolerance.
This trend reaches far beyond Asia. Skin microbiome care is now a global formulation and claims territory, and Asian consumers are among the most attentive to it. [Lien interne : dossier microbiome CTN]
2. Biotech actives and skin longevity
The focus is shifting from anti-ageing towards long-term skin resilience, a major theme of in-cosmetics Asia 2026. Recombinant growth factors, precision ferments, peptides, PDRN and exosomes are the new star ingredients. Their promise is not an immediate effect but a lasting improvement in skin quality, which changes the way their efficacy has to be measured.
3. K-beauty 2.0 and J-beauty
K-beauty, whose influence continues to grow worldwide, is moving from trend to benchmark. Its next phase will be even more firmly grounded in science and AI, with ingredients targeting the skin barrier and drawn from dermocosmetics. J-beauty adds its own emphasis on long-term skin health and sensory experience, two dimensions that can be measured as well.
4. Evidence as the standard
Multi-step routines, messaging that equates irritation with efficacy and fear-based “clean” positioning are losing ground. Consumers demand transparency, expect clinical and biometrological substantiation of product promises, and look for scientifically demonstrated results.
Personalisation through AI-based diagnostic tools is moving from novelty to established trend. Its credibility, however, will only ever match that of the data behind it.
What these trends mean for cosmetic testing
Each of these trends raises a question that only a study can answer. Does a sunscreen protect under real conditions of use? Is a postbiotic well tolerated by sensitive skin? Does a longevity active deliver visible results over time?
The more demanding the claim, the more specific the method must be. Here is how each trend translates into testing needs.
Testing skin barrier and microbiome claims
A “barrier-safe” claim rests on two kinds of evidence: efficacy and tolerance. Barrier function is typically assessed by measuring transepidermal water loss (TEWL) and skin hydration with instrumental methods, before and after use. Tolerance is demonstrated through studies on sensitive or reactive skin panels under dermatological control, sometimes completed by stinging tests.
Microbiome claims call for dedicated methods: skin sampling followed by sequencing to describe the composition and diversity of the bacterial community, and in vitro or ex vivo models to explore the mechanism of action. The wording of the claim (respects, preserves, rebalances) determines which study design is needed.
Proving long-term results for biotech and longevity actives
A longevity claim implies duration. Studies therefore run over several weeks or months, with instrumental measurements of elasticity, wrinkles, skin texture or radiance, often supported by 3D imaging. Ex vivo models on human skin explants help document how innovative actives such as peptides or ferments work at the tissue level.
Sun protection under real conditions of use
In Asia, sun protection is a daily habit, and the expectations go beyond the SPF figure. In vivo SPF and UVA protection testing follow ISO standards, and many Asian markets also expect a PA rating. Studies under real conditions of use, such as resistance to water, sweat or humidity, help substantiate claims that matter in tropical climates.
Why the panel matters as much as the protocol
A study is only as relevant as the population it is carried out on. Skin type, phototype, climate and local habits all influence results, particularly for pigmentation, sensitivity and acne. For brands targeting Asian consumers, working with a laboratory familiar with the local population and conditions makes the evidence both stronger and more convincing.
Focus on Thailand, host country of in-cosmetics Asia
A skincare-led market, online and in store
Thailand’s beauty and personal care market is projected to exceed USD 7.1 billion by the end of 2025, with expected annual growth of around 4.6% through to 2030. Skincare accounts for nearly half of the market value, well ahead of make-up at around 20%.
Purchasing habits are divided. Almost half of beauty purchases are made online, yet physical retail, convenience stores included, continues to attract far greater footfall.
What Thai consumers are looking for
Thai consumers’ concerns are distinctive. Hyperpigmentation, sensitivity, acne and an impaired skin barrier are cited most frequently, with acne particularly prevalent among Gen Z and Millennials.
Search behaviour reflects this. In 2024, searches for salicylic acid rose by more than 65% on Thai e-commerce platforms, and those for Centella asiatica by 48%. According to Mintel, 72% of Thai Gen Z consumers attach great importance to proactive measures aimed at preserving the future appearance of their skin. Prevention is thus becoming a purchase driver.
For testing, these concerns point to clear priorities: anti-acne efficacy assessed by dermatological lesion counting and sebum measurement, brightening claims supported by colorimetry and imaging, and tolerance studies for formulas aimed at sensitive skin.
Regulation: the burden of proof lies with the brand
Thailand operates a notification system under the Cosmetics Act of 2015 and its 2022 amendment, rather than requiring pre-market approval. In practice, the onus is on brands to hold the evidence substantiating their claims. A well-designed study is therefore not only a marketing asset: it is part of a brand’s compliance file.
Find the right laboratory for your claims
Skinobs is the global platform for cosmetic testing, used by more than 9,000 professionals in 124 countries. Brands can search clinical, preclinical and instrumental methods by claim, by type of study and by country, and identify the laboratories able to carry out the right test on the right population. [Lien : plateforme Skinobs]
Meet Skinobs at in-cosmetics Asia 2026
This is precisely the conversation we wish to open in Bangkok. in-cosmetics Asia will take place from 3 to 5 November 2026 at BITEC, with more than 770 exhibitors expected, around 10% more than in 2025.
Come and meet the Skinobs team on stand AA33 to discuss your target markets and the tests capable of substantiating your claims.
